Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO)
ARVO Update: Evolving Strategies for Diabetic Macular Edema
Seattle, Washington / May 5-9, 2013
Guest Editor: R. Geoff Williams, MD Southern Alberta Eye CenterCanada IntroductionAn ongoing evolution in the treatment of diabetic macular edema (DME) is being driven by an expansion of therapeutic options. At the 2013 Annual...
PHYSICIAN PERSPECTIVE - Get Up to Date - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Regina Qu’Appelle Health Region
May 2013
Reviewed and edited by: William Semchuk, MSc, PharmD, FCSHPManager, Clinical Pharmacy ServicesRegina Qu’Appelle Health RegionAssistant Clinical ProfessorCollege of Medicine, and College of Pharmacy and NutritionUniversity of...
PHYSICIAN PERSPECTIVE - Viewpoint based on presentations from the 108th Annual Meeting of the American Urological Association
New Oral Oncolytics: Major Step Forward in the Management of Metastatic Castrate-Resistant Prostate Cancer
San Diego, California / May 4-8, 2013
Reviewed and edited by: Fred Saad, MD, FRCSProfessor and Chief of Urology Director of Urologic OncologyU of M Endowed Chair in Prostate CancerUniversity of Montreal Hospital CentreUniversité de MontréalMontreal,...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
Centre Hospitalier Universitaire de Montréal
April 2013
Reviewed and edited by: André Kokis, MD, FRCPC, FACCCardiologistHead of Interventional CardiologyCentre Hospitalier Universitaire de MontréalAssociate Professor of medecineUniversité de MontréalMontreal,...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Strategies Evolve to Gain Control of Complicated Gram-Positive Infections
Berlin, Germany / April 27-30, 2013
Berlin - Due to evolving patterns of susceptibility, empiric and first-line therapies for challenging gram-positive infections must be adjusted, according to a series of reports at ECCMID. Alternatives to vancomycin, which is identified as...
PRIORITY PRESS - 23rd European Congress on Clinical Microbiology and Infectious Diseases
Recent Developments Promise New Guidelines for Management of C. difficile
Berlin, Germany / April 27-30, 2013
Berlin - Broad initiatives now underway are poised to stem the morbidity and mortality driven by a persistent rise in the incidence of Clostridium difficile infection (CDI). Due to progress in understanding risk factors and an expansion of...
PHYSICIAN PERSPECTIVE - Get with the PROTOCOL - A Regional Perspective on the Evidence and Resulting Changes in ACS Protocol
St. Michael’s Hospital
April 2013
Reviewed and edited by: David H. Fitchett, MB, ChB, MD, FESC, FRCPCCardiologistSt. Michael’s HospitalToronto, Ontario IntroductionAntiplatelet therapy in the management of acute coronary syndromes (ACS) has recently been revised at...
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
New Insights in the Treatment of Atypical Hemolytic Uremic Syndrome
Montreal, Quebec / April 24-28, 2013
Montreal - Atypical hemolytic uremic syndrome (aHUS) is a rare condition caused by a genetic or acquired deficiency in the complement system. Its features include progressive and potentially fatal involvement of the kidneys and circulatory...
PRIORITY PRESS - Annual General Meeting of the Canadian Society of Nephrology
Exploring B-cell Targeted Therapy in the Management of Glomerulonephritis
Montreal, Québec / April 24-28, 2013
Montreal - Treatment of glomerulonephritis has long been dependent on the use of steroids plus cytotoxic or antiproliferative drugs. With the success of therapeutic monoclonal agents in other autoimmune diseases, their use in...